Representational image of pharmaceutical medication | Photographer: Chris Ratcliffe/Bloomberg
Representational image of pharmaceutical medication | Photographer: Chris Ratcliffe/Bloomberg
Text Size:

San Francisco: Alphabet Inc. said it has created a new company, called Isomorphic Labs, to use artificial intelligence for drug discovery.

The new division was spun out of DeepMind, the London research lab of Google’s parent company. DeepMind’s algorithms have made huge advances in predicting the shapes of proteins, a technology that could speed up the development of new drugs and upend the pharmaceutical industry.

In a blog post Thursday announcing the move, Demis Hassabis, the co-founder and head of DeepMind, described Isomorphic Labs as “a commercial venture with the mission to reimagine the entire drug discovery process from the ground up with an AI-first approach.”

Hassabis will be chief executive officer for the new Alphabet company during its “first phase,” a spokesperson said in an email. He will also continue to serve as the head of DeepMind.

Alphabet already has other ventures in medicine. Verily, a biotech unit, has had a wide range of products, but more recently focused on crunching data with partners in the pharmaceutical and health care industry. Calico, a life-extension research firm launched in 2013, has said very little publicly about its work. –Bloomberg 

Also read: Pharma industry warns of Covid drug shortages as raw materials prices surge 200%


Subscribe to our channels on YouTube & Telegram

Why news media is in crisis & How you can fix it

India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises.

But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle.

ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here.

Support Our Journalism